Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Swany and Polygiene takes personal safety essentials to a new level with a ViralOff® series

With more than 90 years of cutting-edge research, design, and manufacturing experience, Swany is committed to providing the best in performance products. Now, together with Polygiene, they have created an entire range of self-sterilizing, anti-microbially treated products featuring masks, gloves, balaclavas, and neck gaiters. The idea is to give people a range of products that are close to mouth, hands, nose and eyes – and to make them essentially self-cleaning when it comes to viruses. Since they not only inhibit viruses but also odors, they do not need to be washed and will

Swedencare AB (publ) intends to carry out a directed new share issue as part of the financing of the acquisitions of Nutravet (UK) Limited and the operations conducted by Animal Pharmaceuticals Inc.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Swedencare AB (publ) (”Swedencare” or the ”Company”) today announces its intention to carry out a directed new share issue of approximately SEK 300 million to Swedish and

Swedencare AB (publ) acquires the operations of an American Pet Health company focused on the Veterinary sector

Non-official translation of the original Swedish press release Swedencare AB (publ) (”Swedencare”) acquires the operations of the American Pet Health company, Animal Pharmaceuticals Inc. (”Animal Pharmaceuticals”). The purchase price amounts to approximately 131 million SEK with a possible additional purchase price of maximum 87 million SEK, dependent on the additional purchase price the cash consideration will consist of approximately 91-178 million SEK and a directed new share issue of 251 994 shares in Swedencare to the seller upon closing, which is expected to take place on October 1st,

Swedencare AB (publ) acquires leading British Animal Health company

Non-official translation of the original Swedish press release Swedencare AB (publ) (”Swedencare”) acquires 100% of the British company Nutravet (UK) Limited (“Nutravet”). The purchase price amounts to approximately 375 million SEK and consists of a cash amount of approximately 281 million SEK and a directed new share issue of 580 769 shares in Swedencare to the seller upon closing, which is expected to take place on October 1st, 2020. Through the acquisition Swedencare will receive a comprehensive and unique product portfolio of nutraceuticals in the premium segment for dogs, cats and

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 24.09.2020

United Bankers Corporation NOTIFICATION 24.09.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 24.09.2020 Date 24.09.2020Exchange transaction BuyShare class UNIAVAmount 1,850Average price/share 8.7000 EURHighest price/share 8.7000 EURLowest price/share 8.7000 EURTotal price 16,095.00 EUR The shares held by United Bankers Corporation on 24.09.2020: UNIAV 16,385   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

September 24, 2020 - On May 19, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of May 19, 2020. According to the programme, Asetek A/S will in the period until September 30, 2020 buy back own shares up to a maximum value of USD 4.5 million and with a maximum of 1,038,082 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and  ommission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

Realfiction announces a clarification regarding its patent pending ECHO display technology

Realfiction Holding AB (“Realfiction”) announces a clarification on the status of the company’s patent-pending ECHO 3D display technology. This clarification is published in response to the many questions received from shareholders related to the press release on the publication of the international ECHO patent application, and presentation of more detailed information on the technology, that was published earlier today.“The whole Realfiction team is excited about the strong shareholder interest in our ECHO technology, and we always strive to deliver up-to-date information on our progress.

BioStock: Chordate Medical tackles chronic migraines

About every seventh person in Sweden suffers from migraine – a disease characterised by intense and throbbing headaches in combination with a number of other ailments. Patients suffering from chronic migraine have headaches every other day, on average, which leads to an enormous burden on both the individual and on society as a whole. Chordate Medical wants to play a part in reducing this burden with a treatment called Kinetic Oscillation Stimulation – a fast, nerve-stimulating treatment with the potential to be both long-lasting and without unexpected side effects.Read the full article at

Alligator Bioscience launches a new immuno-oncology concept

Lund, Sweden, September 24, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company launches a new concept for patient specific immunotherapy, called Neo-X-Prime. Alligator presents the concept at the scientific congress 11th World Bispecific Summit held September 22-24, 2020. The new concept, based on Alligator’s bispecific format RUBY™, build on bispecific antibodies that physically connect tumor debris from the patient’s cancer cells with the relevant immune cells, resulting in strong and tumor selective immune activation. This is thought to increase

ContextVision - Company presentation held at shareholder Webinar

Stockholm, September 24[th], 2020 – Today ContextVision presented the company at a shareholder webinar arranged by Norne and ContextVision. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com. ### About ContextVision ContextVision is a medical technology software company

#20-339 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete

#20-338 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Solteq Plc issues new notes in a nominal amount of EUR 23 million and redeems its outstanding notes due 2021

Solteq Plc, Inside information, 24 September 2020 at 5:15 pm EESTSolteq Plc (“Solteq” or the “Company”) issues new euro-denominated senior unsecured fixed rates notes in a nominal amount of EUR 23 million (the “New Notes”). The New Notes, which will mature on 1 October 2024, are targeted mainly to institutional investors and are callable before their final maturity. The New Notes have an issue price of 100 per cent of their nominal amount and bear a fixed interest rate of 6.00 per cent per annum. The proceeds from the issue will be used for the refinancing of the Company’s existing notes

Resolutions at the extraordinary general meeting in Evolution Gaming Group AB (publ)

At the extraordinary general meeting in Evolution Gaming Group AB (publ) on 24 September 2020, it was resolved on an authorisation for the board of directors to resolve on the issuance of shares by reason of the public offer to the shareholders of NetEnt AB (publ) which the company announced on 24 June 2020.Authorisation to issue sharesThe extraordinary general meeting resolved to authorise the board of directors to, on one or several occasions prior to the next annual general meeting, resolve on an increase of the share capital of the company by way of the issuance of the number of new

Showcasing what is currently possible in dentistry

Zahngesundheit Frechen is one of the largest dental clinics in the greater Cologne area in Germany, where the clinic specialises in orthodontics, implantology, aesthetic dentistry and dental prophylaxis. To offer their patients the best possible dental care, the clinic owners and their team have high requirements for the dental technology they use. One of the owners, Maximilian von Kleinsorgen, reveals why the owner trio decided to invest in Planmeca as they were expanding their clinic. With more than 50 employees, Zahngesundheit Frechen is one of the largest dental clinics in the

Eco Wave Power’s CEO Announces Exciting First Results of Performance Improvements and Significant Cost Reductions from Gibraltar Wave Energy Project

Stockholm, Sweden, 24 September 2020 --- Today, Eco Wave Power participated in a digital investor event focused on Renewable Energy & Cleantech, arranged by ABG Sundal Collier. The full presentation by CEO Inna Braverman is available to watch on Eco Wave Power’s YouTube channel in the following link:  https://www.youtube.com/watch?v=f2SAB5HNjYk&feature=youtu.be Speaking to institutional investors and other investors invited by ABG Sundal Collier, Eco Wave Power’s CEO Inna Braverman presented the company, its current activities, and future plans – including the progress and results

Ingka Group supports more business action on climate change

Ingka Group has given support and signed up to a new guide raising the bar on climate leadership, ’Climate Leadership Now: The new bar for business action on climate change’, published by the We Mean Business coalition*.The We Mean Business coalition  was founded in 2014 to galvanise business leadership on climate change and influence policy in the lead-up to the formation of the Paris Agreement.  The new guide details the action businesses need to take to be considered credible corporate leaders in the 2020s and outlines the case for even

Read original

Ola Tiverman appointed as new President of the subsidiary Smoltek Semi AB

Smoltek announces that Ola Tiverman will take on a new role as President of the wholly owned subsidiary Smoltek Semi AB, a business area company entirely focused on licensing technology concepts to the semiconductor and electronics industry.This press release is an English version of the previously published Swedish version.Smoltek Semi AB was established in January 2019, with the aim of utilising the subsidiary as a contractual party vis-à-vis external licensees through sublicensing of Smoltek AB's patent portfolio and know-how. As a result of the expansion and streamlining of Smoltek

Company Announcement No. 88, 2020 – EURIBOR3, Fixing of coupons with effect as from 1 October 2020

The coupons for the FRNs listed below will change taking effect 1 October 2020. The new coupons will be in force from 1 October 2020 – 31 December 2020. FRNs without interest rate cap, EURIBOR3: ISIN-codeDK0002040138, maturity 2021, new coupon as per 1 October 2020:                   -0.20 % p.a.  ISIN-codeDK0002043231, maturity 2022, new coupon as per 1 October 2020:                   -0.23 % p.a. Questions can be directed to Torben Jurlander phone no. +45 55 47 41 99.  Yours faithfully Nordea Kredit Realkreditaktieselskab

Contract extensions with key clients in Norway

Solstad Offshore ASA (“Solstad”) is pleased to announce contract extensions with key clients Equinor and Aker BP. Equinor has declared an option to extend the contract for anchor handling vessel Normand Ferking with 1 more year to November 2021. Equinor has the option to extend the contract with further 2 x 1 years. Normand Ferking has been on contract with Equinor since 2007. In addition, as part of the Frame Agreement between Aker BP ASA and Solstad, Aker BP ASA has extended present contract for the PSV Far Solitaire with 12 months, commencing 1st January 2021. Both vessels will

Manufacturing precision engineering parts with SabriScanMethod®

SabriScan Oy a leading solution provider with 20 years of experience in manufacturing precision engineering parts for various applications. The ingenious SabriScanMethod® manufacturing methods are suitable for manufacturing reflective and refractive precision optics, mold inserts and other machine parts and tools. For example different optics; prisms and fresnels, gear wheels, segments, pelton and kaplan turbines. In “SabriScan Method®”, there little/no need to polish the reflective optics inserts after manufacturing. This will preserve the shape of the optics as designed thus resulting

Fazer closes Karkkila factory and moves operations to factory in Lappeenranta

Fazer has evaluated different options for developing the production of xylitol pastilles and chewing gum and has decided to close the production facility in Karkkila and to move its operations to Fazer’s factory in Lappeenranta. Karkkila does not have the same development possibilities as Fazer’s factory in Lappeenranta. Transferring the production to Lappeenranta will enable the needed efficiency and capability building to remain competitive in the long run. To better respond to the evolving consumer demand, Fazer needs to develop the production of the xylitol products to enable

Sobrera Pharma and Recipharm in collaboration to advance a new treatment for patients with Alcohol Use Disorder

Swedish life science company, Sobrera Pharma, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder (AUD). A phase II study is already ongoing to test the efficacy and safety of the new therapy, which acts through dopamine, which plays an important role in the reward system. Preclinical and clinical data form the basis for the development of a unique new product to be developed at Recipharm’s Centre of Excellence in Oral

There are no items matching the current filter
There are no more items matching the current filter
Back to top